Injectable Cholesterol-Lowering Drug Continues to Show Promise

PCSK9-inhibitors, combined with statins, can bring cholesterol levels down significantly and may help reverse the build-up of plaque in the arteries.

By
estaff
-
Published:
0
A Cleveland Clinic study found that a newer, injectable drug to fight cholesterol appears to reverse plaque buildup in the arteries within 18 months. In the study, patients were given injections of the PCSK9 inhibitor evolocumab (Repatha), as well as standard daily doses of a statin.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access

RELATED ARTICLESMORE FROM AUTHOR